Biopharma Dealmaking Quarterly Statistics, Q1 2014
A look at financing, M&A, and alliance activity January–March 2014
Executive Summary
Biopharma financing totaled $9.8 billion, a 53% increase over Q4 2013. Twenty-two M&As were completed with a combined potential value reaching $31.3 billion, and there were 103 biopharma alliances totaling $1.9 billion in potential pre-commercialization value, down 30% from the previous quarter.